Medpace

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medpace and other ETFs, options, and stocks.

About MEDP

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.

CEO

August James Troendle

CEOAugust James Troendle

Employees

6,200

Employees6,200

Headquarters

Cincinnati, Ohio

HeadquartersCincinnati, Ohio

Founded

1992

Founded1992

Employees

6,200

Employees6,200

MEDP Key Statistics

Market cap

13.01B

Market cap13.01B

Price-Earnings ratio

28.95

Price-Earnings ratio28.95

Dividend yield

—

Dividend yield—

Average volume

269.09K

Average volume269.09K

High today

$461.92

High today$461.92

Low today

$445.01

Low today$445.01

Open price

$458.82

Open price$458.82

Volume

345.30K

Volume345.30K

52 Week high

$628.92

52 Week high$628.92

52 Week low

$301.90

52 Week low$301.90

Stock Snapshot

The current Medpace(MEDP) stock price is $455.66, with a market capitalization of 13.01B. The stock trades at a price-to-earnings (P/E) ratio of 28.95.

During the trading session on 2026-06-22, Medpace(MEDP) shares reached a daily high of $461.92 and a low of $445.01. At a current price of $455.66, the stock is +2.4% higher than the low and still -1.4% under the high.

Trading volume for Medpace(MEDP) stock has reached 345.3K, versus its average volume of 269.09K.

The stock's 52-week range extends from a low of $301.90 to a high of $628.92.

MEDP News

Simply Wall St 14h

How Investors May Respond To Medpace Holdings Joining Turtle Creek’s Clinician-Led CRO Portfolio

Turtle Creek Asset Management recently added Medpace Holdings, Inc. to its Q1 2026 portfolio, citing the CRO’s clinician-led focus on small and mid-sized biopha...

Simply Wall St 7d

Medpace Holdings Stock Valuation Check After Mixed Recent Share Performance

Advertisement Medpace Holdings overview after recent share performance Medpace Holdings (MEDP) has drawn fresh attention after a solid move in its share price...

Analyst ratings

60%

of 15 ratings

Buy

33.3%

Hold

60%

Sell

6.7%

People also own

Based on the portfolios of people who own MEDP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.